Veterinary Orodispersible Tablets Global Market Report 2026

Veterinary orodispersible tablets are fast-dissolving oral formulations for animals that disintegrate in the mouth without the need for water, making administration easy and stress-free. They improve treatment compliance by simplifying dosing and ensuring accurate medication delivery and are particularly suitable for companion animals such as dogs and cats. In addition, veterinary orodispersible tablets provide increased convenience for pet owners and may contribute to a faster therapeutic effect in certain treatments.

The primary product types of veterinary orodispersible tablets include analgesics, antibiotics, anthelmintics, antipyretics, and other related formulations. Analgesics are fast-dissolving veterinary tablet formulations developed to deliver rapid therapeutic effects through oral dispersion without the need for water administration. These formulations are designed for various animal categories, including companion animals, livestock animals, and other animal types. Distribution channels for these products include veterinary hospitals, online pharmacies, and other supply networks. Their major applications cover infectious diseases, pain management, gastrointestinal disorders, and several other therapeutic uses. The key end users include veterinary clinics, veterinary hospitals, research institutes, and other veterinary healthcare providers.

Tariffs are influencing the veterinary orodispersible tablets market by increasing the cost of imported pharmaceutical excipients, flavoring agents, and advanced polymer-based disintegration technologies used in tablet formulation. This is affecting production costs and limiting access to specialized formulation materials, particularly in import-dependent regions such as Asia-Pacific and Latin America. The most impacted segments include analgesics, antibiotics, and combination drug formulations due to their reliance on globally sourced active pharmaceutical ingredients and excipients. However, tariffs are also encouraging local manufacturing of veterinary pharmaceuticals, boosting regional formulation capabilities, and driving innovation in cost-effective and palatable tablet technologies for companion animals.

The veterinary orodispersible tablets market research report is one of a series of new reports from The Business Research Company that provides veterinary orodispersible tablets market statistics, including veterinary orodispersible tablets industry global market size, regional shares, competitors with a veterinary orodispersible tablets market share, detailed veterinary orodispersible tablets market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary orodispersible tablets industry. This veterinary orodispersible tablets market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The veterinary orodispersible tablets market size has grown strongly in recent years. It will grow from $1.12 billion in 2025 to $1.21 billion in 2026 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to poor medication compliance in companion animals, difficulty in oral dosing of traditional veterinary tablets, limited availability of palatable veterinary formulations, reliance on conventional solid oral dosage forms, lack of advanced drug delivery technologies in veterinary medicine.

The veterinary orodispersible tablets market size is expected to see strong growth in the next few years. It will grow to $1.65 billion by 2030 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to rising demand for pet-friendly medication formats, increasing adoption of precision drug delivery systems, growth in companion animal healthcare expenditure, advancement in veterinary pharmaceutical formulation technologies, expanding focus on treatment compliance and ease of administration. Major trends in the forecast period include development of taste-masked formulation technologies to improve palatability of veterinary orodispersible tablets, increasing adoption of fast-disintegrating polymer matrices for enhanced drug dissolution in animal oral delivery, rising use of precision-compounded low-dose orodispersible tablets for companion animal therapies, growing integration of advanced excipient engineering to improve stability and disintegration speed in veterinary tablets, expansion of stress-free pet medication delivery systems to improve treatment adherence in animals.

The expanding companion-animal healthcare spending by pet owners is expected to propel the growth of veterinary orodispersible tablets going forward. Companion-animal healthcare spending by pet owners refers to the total expenditure by individuals on veterinary services, preventive care, treatments, and related health products for their pets. The increase in companion-animal healthcare spending by pet owners is growing due to the rising perception of pets as family members, which encourages owners to invest more in preventive care, advanced treatments, and overall well-being. The growing demand for companion-animal healthcare spending by pet owners is driving the adoption of veterinary orodispersible tablets, as these convenient and palatable formulations enhance compliance, ensure accurate dosing, and support the increasing focus on pet wellness and preventive care. For instance, in March 2025, according to the American Pet Products Association, total US pet industry expenditures reached $147 billion in 2023, increasing further to $152 billion in 2024, reflecting continued year-over-year growth. Therefore, expanding companion-animal healthcare spending by pet owners is driving the growth of the veterinary orodispersible tablets market.

The rising pet ownership globally is expected to propel the growth of the veterinary orodispersible tablets market going forward. Pet ownership globally refers to the proportion of households worldwide that keep companion animals, reflecting the prevalence and cultural adoption of pets across different regions. The increase in pet ownership globally is driven by the growing trend of considering pets as family members, which encourages individuals and households to adopt companion animals for companionship, emotional support, and lifestyle enrichment. The rising global pet ownership is driving demand for veterinary orodispersible tablets, as a larger companion-animal population increases the need for convenient, palatable, and easily administered medications to ensure health, compliance, and overall well-being. For instance, in March 2025, according to the American Pet Products Association, currently, 94 million households in the U. S. own at least one pet, representing an increase from 82 million households in 2023. Therefore, rising pet ownership globally is driving the growth of the veterinary orodispersible tablets market.

The expansion of veterinary healthcare infrastructure is expected to propel the growth of the veterinary orodispersible tablets market going forward. Veterinary healthcare infrastructure refers to the network of facilities, trained professionals, and medical resources dedicated to diagnosing, treating, and managing animal health. The growing development of veterinary infrastructure is primarily driven by the increasing rate of pet ownership, as more households across developed nations adopt companion animals, increasing the need for accessible and well-equipped veterinary care facilities. The expansion of veterinary healthcare infrastructure directly boosts demand for advanced and easy-to-administer pharmaceutical dosage forms designed for animals of varying sizes and conditions. For instance, in December 2023, according to the American Veterinary Medical Association, the total number of veterinarians in the United States increased from approximately 124,069 in 2022 to approximately 127,131 in 2023, reflecting an increase of over 3,000 professionals within a single year. Therefore, the expansion of veterinary healthcare infrastructure is driving the growth of the veterinary orodispersible tablets market.

Major companies operating in the veterinary orodispersible tablets market are Zoetis Inc. , Elanco Animal Health Incorporated, Ceva Sante Animale S. A. , Merck & Co. Inc. , Virbac S. A. , Phibro Animal Health Corporation, HIPRA S. A. , Vetoquinol S. A. , Norbrook Laboratories Limited, KRKA d. d. Novo mesto, Intas Pharmaceuticals Limited, Boehringer Ingelheim Animal Health GmbH, Hester Biosciences Limited, Huvepharma EOOD, AdvaCare Pharma, ODT Pharmaceuticals Inc. , Provet Pharma Private Limited, Kyoritsu Seiyaku Corporation, Ani Healthcare Private Limited, Vee Remedies Private Limited, Skyec Drugs and Pharmaceuticals Private Limited, Dotcom Pharma Private Limited, Alicanto Vetcare Private Limited, Vetraise Remedies Private Limited, Vetson Healthcare Private Limited

North America was the largest region in the veterinary orodispersible tablets market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary orodispersible tablets market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the veterinary orodispersible tablets market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The veterinary orodispersible tablets market consists of sales of anti-inflammatory tablets, anti-seizure tablets, anti-diabetic tablets, anti-allergic tablets, gastroprotective tablets, antibiotic tablets, cardiovascular support tablets, respiratory support tablets, and immune support tablets. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Veterinary Orodispersible Tablets Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses veterinary orodispersible tablets market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for veterinary orodispersible tablets ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The veterinary orodispersible tablets market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product Type: Analgesics; Antibiotics; Anthelmintics; Antipyretics; Other Product Types
• 2) By Animal Type: Companion Animals; Livestock Animals; Other Animal Types
• 3) By Application: Infectious Diseases; Pain Management; Gastrointestinal Disorders; Other Applications
• 4) By End User: Veterinary Clinics; Veterinary Hospitals; Research Institutes; Other End Users
• Subsegments:
• 1) By Analgesics: Non Steroidal Anti Inflammatory Analgesics; Opioid Analgesics; Local Analgesics; Combination Analgesics; Herbal Analgesics
• 2) By Antibiotics: Beta Lactam Antibiotics; Tetracycline Antibiotics; Aminoglycoside Antibiotics; Macrolide Antibiotics; Fluoroquinolone Antibiotics
• 3) By Anthelmintics: Benzimidazole Anthelmintics; Macrocyclic Lactone Anthelmintics; Imidazothiazole Anthelmintics; Praziquantel Based Anthelmintics; Combination Anthelmintics
• 4) By Antipyretics: Non Steroidal Anti Inflammatory Antipyretics; Acetaminophen Based Antipyretics; Aspirin Based Antipyretics; Herbal Antipyretics; Combination Antipyretics
• 5) By Other Product Types: Antihistamines; Vitamins And Supplements; Probiotics; Cardiovascular Agents; Respiratory Agents
• Companies Mentioned: Zoetis Inc.; Elanco Animal Health Incorporated; Ceva Sante Animale S.A.; Merck & Co. Inc.; Virbac S.A.; Phibro Animal Health Corporation; HIPRA S.A.; Vetoquinol S.A.; Norbrook Laboratories Limited; KRKA d.d. Novo mesto; Intas Pharmaceuticals Limited; Boehringer Ingelheim Animal Health GmbH; Hester Biosciences Limited; Huvepharma EOOD; AdvaCare Pharma; ODT Pharmaceuticals Inc.; Provet Pharma Private Limited; Kyoritsu Seiyaku Corporation; Ani Healthcare Private Limited; Vee Remedies Private Limited; Skyec Drugs and Pharmaceuticals Private Limited; Dotcom Pharma Private Limited; Alicanto Vetcare Private Limited; Vetraise Remedies Private Limited; Vetson Healthcare Private Limited
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.